FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Pinto Cynthia Buch
2. Date of Event Requiring Statement (MM/DD/YYYY)
7/1/2020 

3. Issuer Name and Ticker or Trading Symbol

ENDOLOGIX INC /DE/ [ELGX]
(Last)        (First)        (Middle)

2 MUSICK
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Interim CFO /
(Street)

IRVINE, CA 92618      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
7/10/2020 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 19198 (1)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase 12/30/2019 12/30/2028 Common Stock 12255.0 (2)$7.45 D  
Option to Purchase 9/5/2019 8/5/2029 Common Stock 15867.0 (3)$6.67 D  
Option to Purchase 9/10/2020 9/10/2026 Common Stock 1572.0 (4)$4.71 D  

Explanation of Responses:
(1) On July 10, 2020, the reporting person filed a Form 3 which inadvertently reported 24,549 shares beneficially owned. In fact, as reported in this amendment, the reporting person had 19,198 shares beneficially owned as of the report date, July 1, 2020.
(2) 100% of the option award vested on December 30, 2019.
(3) Options vest ratably over thirty-six months.
(4) The reporting person received this stock option pursuant to the option exchange program. The options vest in three equal annual installments over a three-year period commencing on September 10, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Pinto Cynthia Buch
2 MUSICK
IRVINE, CA 92618


Interim CFO

Signatures
Cynthia Buch Pinto by Timothy N. Brady Attorney-in-Fact for Reporting Person8/14/2020
**Signature of Reporting PersonDate

Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Endologix Charts.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Endologix Charts.